Join us to hear visiting scientist Professor Steve Dalton from the University of Georgia discuss his research on on the link between cell cycle, epigenetics and cell fate determination.
VENUE: Level 5 Seminar Room, Melbourne Brain Centre, The University of Melbourne
TIME: 4-5PM (Refreshments to follow)
TITLE: Signaling pathways connect the cell cycle to epigenetics and cell fate determination
ABSTRACT: The Dalton lab is interested in the basic biology of pluripotent cells, including mouse and human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). These studies will help understand more about early stages of embryonic development and are directed towards a better understanding of cell cycle control, the pluripotent state and cell fate decisions made by pluripotent cells. A second major effort in the lab is dedicated towards developing cell therapies for cardiovascular disease, diabetes and neurological disorders. The Dalton lab has been particularly successful in developing methods for the generation of cardiac and neural progenitor cells which are being evaluated in animal models.
BIO: Stephen Dalton has been Professor and GRA Chair in Molecular Cell Biology in the Department of Biochemistry and Molecular Biology at the University of Georgia since 2003. In 2012 he was appointed founding Director of the Center for Molecular Medicine. Dr. Dalton received his Ph.D. from the University of Adelaide, working in the Department of Biochemistry with Dr. Julian Wells. This was followed by post-doctoral research at the Imperial Cancer Research Fund in Richard Treisman's laboratory (ICRF; Cancer UK), London. In 1992 he joined the Roche Institute for Molecular Biology in New Jersey as a faculty member and as an adjunct faculty member at Columbia University, New York. Dr. Dalton returned to Australia where he was a Senior Lecturer at the University of Adelaide. Dr. Dalton sits on the scientific editorial boards of several journals including ‘Stem Cells’ and ‘Regenerative Medicine’ and has served on numerous national and international advisory panels. He is a Georgia Cancer Coalition Distinguished Scholar and has a research focus on stem cell biology, developmental biology and regenerative medicine. Dr. Dalton’s research is funded by the National Institutes of Health, the Georgia Research Alliance and private organizations.